DexCom (DXCM) issued the following statement in response to speculation following the developments at Silicon Valley Bank (SIVB), including a recent CNBC article: "Dexcom does not have material exposure to the developments at Silicon Valley Bank, including with respect to the company’s cash deposits. Although the company has worked successfully with SVB for many years, Dexcom does not have any exclusive banking relationship with SVB. As noted in Dexcom’s recent filing on form 10-K, the company currently retains approximately $2.5B in cash, cash equivalents, and short-term marketable securities. Approximately $2.7M of this amount is held at SVB."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on DXCM:
- DexCom pullback on Abbott news a buying opportunity, says Jefferies
- BofA says buy DexCom on weakness after Abbott’s Libre gets pump integration
- DexCom down more than 7% after FDA gives nod to Abbott CGM sensors
- DexCom put volume heavy and directionally bearish
- CMS earlier Basal coverage approval adds confidence for DexCom, says BofA
